We use cookies to ensure you get the best experience on our website. For more information on how we use cookies, please see our cookie policy.
By clicking "Accept", you agree to our use of cookies.
Learn more
Common product name: Promovia HB
Selected variant: 50mg/2mL
Patented formula based on Sodium Hyaluronate and Trehalose - Long-term symptomatic relief.
Form
Injection - Pre-filled Sterile Syringes (50mg, 100mg)
Promovia HydroBalance is a synergistic combination of medium and low molecular weight hyaluronic acid and trehalose. It is a class III, sterile, injectable medical device providing immediate and long-term viscosupplementation to joints.
Synergistic Formulation: Hyaluronic acid lubricates the joint and provides shock-absorbing properties. Trehalose stabilizes the HA molecule and protects cells against osmotic stress. This combination offers longer residence time in the joint and enhanced efficacy.
Hyaluronic acid + Trehalose combination. Class III high risk group. Non-active implant, resorbable (>30 days). Immediate and long-term performance.
Chondropathy
Arthrosis
Arthritis
Official product names, variant labels and common search formats for PROmovia® HydroBalance are listed below.
Playal®
Patented formulation of Sodium Hyaluronate and Niacinamide - High-performance viscoelastic solution series for joint disorders.
PROmovia®
Sodium Hyaluronate based intra-articular injections - High purity hyaluronic acid with viscoelastic properties.
Viscoial
Medical device based on sodium hyaluronate.
Synart
Joint care with medium molecular weight Hyaluronic acid sodium salt.
